Source: Inside Indiana Business

BASi: BASi Adding Pharmacology Testing Options

West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is growing its services. The contract research services company plans to expand its offerings by adding cardiovascular safety pharmacology testing capabilities, a move it says is nearly a...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Robert Leasure, Jr.'s photo - President & CEO of BASi

President & CEO

Robert Leasure, Jr.

CEO Approval Rating

85/100

Read more